• Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.

      Urayama, Kevin Y; Jarrett, Ruth F; Hjalgrim, Henrik; Diepstra, Arjan; Kamatani, Yoichiro; Chabrier, Amelie; Gaborieau, Valerie; Boland, Anne; Nieters, Alexandra; Becker, Nikolaus; Foretova, Lenka; Benavente, Yolanda; Maynadié, Marc; Staines, Anthony; Shield, Lesley; Lake, Annette; Montgomery, Dorothy; Taylor, Malcolm; Smedby, Karin Ekström; Amini, Rose-Marie; Adami, Hans-Olov; Glimelius, Bengt; Feenstra, Bjarke; Nolte, Ilja M; Visser, Lydia; van Imhoff, Gustaaf W; Lightfoot, Tracy; Cocco, Pierluigi; Kiemeney, Lambertus; Vermeulen, Sita H; Holcatova, Ivana; Vatten, Lars; Macfarlane, Gary J; Thomson, Peter; Conway, David I; Benhamou, Simone; Agudo, Antonio; Healy, Claire M; Overvad, Kim; Tjønneland, Anne; Melin, Beatrice; Canzian, Federico; Khaw, Kay-Tee; Travis, Ruth C; Peeters, Petra H M; González, Carlos A; Quirós, José Ramón; Sánchez, María-José; Huerta, José María; Ardanaz, Eva; Dorronsoro, Miren; Clavel-Chapelon, Françoise; Bueno-de-Mesquita, H Bas; Riboli, Elio; Roman, Eve; Boffetta, Paolo; de Sanjosé, Silvia; Zelenika, Diana; Melbye, Mads; van den Berg, Anke; Lathrop, Mark; Brennan, Paul; McKay, James D; Genetics Section, International Agency for Research on Cancer, Lyon, France. (Journal of the National Cancer Institute, 2012-02-08)
      Accumulating evidence suggests that risk factors for classical Hodgkin lymphoma (cHL) differ by tumor Epstein-Barr virus (EBV) status. This potential etiological heterogeneity is not recognized in current disease classification.